Globe News Wire
20 Jan 2026, 16:43 UTC · 39w ago
Verdict
Headline takes no side. We score BN +0.20 — slightly bullish.
+0.20slightly bullish
More positive than 56% of ticker scores this week
Which stocks this story touches
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More positive than 56% of ticker scores this week
Identified as a major operating company in the growing cell-free protein expression and synthetic biology markets.
More positive than 56% of ticker scores this week
Identified as a major company operating in the synthetic biology market.
More positive than 56% of ticker scores this week
Listed as a major company operating in the nutrigenomics market.
More positive than 32% of relationship scores this week
[mutual] Both companies are identified as major operators in the cell-free protein expression market.
More positive than 32% of relationship scores this week
[mutual] Both companies are identified as major operators in the synthetic biology market.
More positive than 32% of relationship scores this week
[mutual] Both companies are identified as major operators in the cell-free protein expression market.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
3d ago
−19.8%
Price is moving against the score
$37.97 vs $47.36 close before publication (Jan 16) · not market-adjusted
BN chart →
